Your browser doesn't support javascript.
loading
Anti-HER2 antibody therapy using gene-transduced adipocytes for HER2-positive breast cancer.
Masuda, Takahito; Fujimoto, Hiroshi; Teranaka, Ryotaro; Kuroda, Masayuki; Aoyagi, Yasuyuki; Nagashima, Takeshi; Sangai, Takafumi; Takada, Mamoru; Nakagawa, Ayako; Kubota, Yoshitaka; Yokote, Koutaro; Ohtsuka, Masayuki.
Afiliación
  • Masuda T; Department of General Surgery, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuoku, Chiba, 260-0856, Japan.
  • Fujimoto H; Department of General Surgery, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuoku, Chiba, 260-0856, Japan. hifujimonty@chiba-u.jp.
  • Teranaka R; Department of General Surgery, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuoku, Chiba, 260-0856, Japan.
  • Kuroda M; Center for Advanced Medicine, Chiba University Hospital, 1-8-1, Inohana, Chuoku, Chiba, 260-8677, Japan.
  • Aoyagi Y; CellGenTech, Inc., 1-8-15, Inohana, Chuoku, Chiba, 260-0856, Japan.
  • Nagashima T; Department of General Surgery, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuoku, Chiba, 260-0856, Japan.
  • Sangai T; Department of General Surgery, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuoku, Chiba, 260-0856, Japan.
  • Takada M; Department of General Surgery, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuoku, Chiba, 260-0856, Japan.
  • Nakagawa A; Department of General Surgery, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuoku, Chiba, 260-0856, Japan.
  • Kubota Y; Department of Plastic, Reconstructive, and Aesthetic Surgery, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuoku, Chiba, 260-0856, Japan.
  • Yokote K; Department of Clinical Cell Biology and Medicine, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuoku, Chiba, 260-0856, Japan.
  • Ohtsuka M; Department of General Surgery, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuoku, Chiba, 260-0856, Japan.
Breast Cancer Res Treat ; 180(3): 625-634, 2020 Apr.
Article en En | MEDLINE | ID: mdl-32124135
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Adipocitos / Receptor ErbB-2 / Anticuerpos Monoclonales Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Breast Cancer Res Treat Año: 2020 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Adipocitos / Receptor ErbB-2 / Anticuerpos Monoclonales Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Breast Cancer Res Treat Año: 2020 Tipo del documento: Article País de afiliación: Japón